Interim analyses, stopping rules and data monitoring in clinical trials in europe
Author:
- 1 March 1993
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 12 (5-6) , 509-520
Abstract
A survey was carried out to identify the current policies of European cooperative groups with respect to interim analyses, stopping rules and data monitoring of ongoing clinical trials. The policies differ widely, from informal interim analyses distributed among all participating investigators, to planned interim analyses carried out by an independent statistician and scrutinized by a data monitoring committee. Different situations clearly call for different policies: for instance, trials of new drugs in AIDS need to be monitored more closely than trials of non‐toxic adjuvant therapies for cancer. Likewise, trials with an immediately measurable end‐point (such as the large‐scale trials in myocardial infarction) need more intensive monitoring than those in which the outcome assessment requires prolonged follow‐up. In all cases, however, it seems useful to articulate explicit data monitoring procedures in the trial protocol. In general, an independent data monitoring committee is essential to advise on the desirability to continue accrual into the trial, or to stop it early.Keywords
This publication has 19 references indexed in Scilit:
- Applying Bayesian ideas in drug development and clinical trialsStatistics in Medicine, 1993
- Interim analysis in clinical trialsStatistics in Medicine, 1991
- Design Considerations for AIDS TrialsNew England Journal of Medicine, 1990
- Statistical Approaches to Interim Monitoring of Medical Trials: A Review and CommentaryStatistical Science, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Comparison of Bayesian with group sequential methods for monitoring clinical trialsControlled Clinical Trials, 1989
- Probabilistic prediction in patient management and clinical trialsStatistics in Medicine, 1986
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- Repeated assessment of results in clinical trials of cancer treatmentBritish Journal of Radiology, 1971